FDA Inspection
PolyPeptide SAPolyPeptide SA – FDA Inspection, Oct 2, 2020
Record Details
This FDA Inspection record concerns PolyPeptide SA, with an inspection on October 2, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- PolyPeptide SA
- Inspection Date
- October 2, 2020
- Product Type
- Drugs
View Company Profile
ID · f7d5c00e-1009-4910-8108-32ce6fcf214c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1178037
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of PolyPeptide SA
5| Date | Classification | Office | Project area |
|---|---|---|---|
| December 18, 2023 | VAI | Drug Quality Assurance | |
| March 16, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 30, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 14, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 16, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for PolyPeptide SA
- FDA Inspection 1312276 - 2023-12-18
- FDA Inspection 1017697 - 2017-03-16
- FDA Inspection 880413 - 2014-05-30
- FDA Inspection 792099 - 2012-06-14
- FDA Inspection 592340 - 2009-06-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.